Rheumatoid arthritis (RA) is an autoimmune/inflammatory disease affecting 0.5 to 1% of adults worldwide and frequently leads to joint destruction and disability. Early diagnosis and early and effective therapy may prevent joint damage and lead to better long-term results. Therefore, reliable biomarkers and outcome measures are needed. Refinement of the understanding of molecular pathways involved…
Advances in Rheumatology Template
Write in a clean editor, then format for Advances in Rheumatology in one click — DocuGuru applies the official BMC (BioMed Central) template with numbered references and exports a submission-ready PDF plus the editable LaTeX source. Free to start.
About the Advances in Rheumatology format
Advances in Rheumatology is a peer-reviewed journal published by BMC (BioMed Central), covering Rheumatoid Arthritis Research and Therapies, Spondyloarthritis Studies and Treatments, Systemic Lupus Erythematosus Research. Over its lifetime it has published 552 papers, which have received 6,200 citations.
| Publisher | BMC (BioMed Central) |
|---|---|
| Reference style | Numbered (Vancouver) Numbered — [1], [2] in the text 1. Smith A, Jones B, Lee C. A representative article title. Advances in Rheumatology. 2023;12(3):45–58.
Formats any DOI in Advances in Rheumatology style. No sign-up. |
| Publishes research in | Rheumatoid Arthritis Research and Therapies Spondyloarthritis Studies and Treatments Systemic Lupus Erythematosus Research Autoimmune and Inflammatory Disorders Research Systemic Sclerosis and Related Diseases |
| ISSN | 2523-3106 |
| Citation impact (2-yr) | 2.8 |
| h-index | 37 |
| i10-index | 197 |
| Open access | Yes — indexed in DOAJ |
| Top institutions publishing here | Universidade Federal de São Paulo |
| Journal website | link.springer.com |
| You get | A submission-ready PDF and the editable LaTeX source — ready to submit. |
Papers published in Advances in Rheumatology per year
Citation impact of Advances in Rheumatology by publication year
Citations each year’s papers have accumulated so far — the most recent years are still building up.
Most-cited papers in Advances in Rheumatology
BACKGROUND: Benzbromarone is a uricosuric drug that has been used in the treatment of gout over the last 30 years. Due to its potent inhibition of the dominant apical (luminal) urate exchanger in the human proximal tubule URAT1, it reduces the urate reabsorption, diminishing serum urate levels and therefore preventing gout flares. Through several clinical…
BACKGROUND: Low back pain is a significant health problem condition due to high prevalence among the general population. Emotions and physical factors are believed to play a role in chronic low back pain. Kinesiophobia is one of the most extreme forms of fear of pain due to movement or re-injury. The purpose of this study…
Hydroxychloroquine and chloroquine, also known as antimalarial drugs, are widely used in the treatment of rheumatic diseases and have recently become the focus of attention because of the ongoing COVID-19 pandemic. Rheumatologists have been using antimalarials to manage patients with chronic immune-mediated inflammatory rheumatic diseases for decades. It is an appropriate time to review their…
BACKGROUND: To determine the burden of Rheumatoid Arthritis (RA) on patients' work productivity and health related quality of life (HRQoL), and examine the influence of several exposure variables; to analyze the progression of RA over 1 year and its impact on work productivity and HRQoL. METHODS: International multicenter prospective survey including patients in 18 centers…